$0.5333
-0.0083-1.53%
Ult. Agg.: Oct 23, 9:42 AM
Aprea Therapeutics (APRE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.22 | $-0.23 | $-0.37 | $-0.10 |
| Actual | $-0.07 | $-0.22 | $-0.32 | $-0.47 |
| Surprise | +68.2% | +4.35% | +13.5% | -370.0% |
| Revenue | ||||
| Estimate | $203200 | — | — | — |
| Actual | $0 | $0 | $3337 | $1848 |
| Surprise | -100.0% | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.08 | $-0.10 | $-0.08 | $-0.08 |
| Revenue | ||||
| Consensus | $124000 | $148000 | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.07 | $-0.22 | 68.2 % |
| Q1 | May 13, 2026 | $-0.22 | $-0.23 | 4.35 % |
| Q4 | Mar 16, 2026 | $-0.32 | $-0.37 | 13.5 % |
| Q3 | Nov 12, 2025 | $-0.47 | $-0.10 | -370.0 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $0 | $203.20K | -100.0 % |
| Q4 | Mar 25, 2025 | $205.82K | $450.00K | -54.3 % |
| Q3 | Nov 7, 2024 | $354.62K | $225.00K | 57.6 % |
| Q2 | Aug 12, 2024 | $561.57K | $50.00K | 1023.2 % |